4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001062993-25-008509
Chief Scientific Officer sold 68,412 shares at $7.35 ($502,828)
- Chief Scientific Officer acquired 68,412 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROBINS HARLAN S · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-05-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +68,412 | $6.32 | $432,364 | 1,347,936 | D |
| 2025-05-01 | Sale : show line 2 in the form 10b5-1 | −68,412 | $7.35 | $502,828 | 1,279,524 | D |
| Open-market sales · 68,412 sh · avg $7.35 · $502,828 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-05-01 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −68,412 | 0 | D |
Loading xslF345X05/form4.xml…